However, it has been reported that in pancreatic ductal adenocarcinoma, KRAS mutations promote the phosphorylation of NADK by PKC, which increases NADK activity and promotes the synthesis of NADPH, promoting the progression of pancreatic cancer20. Here, NADK is linked to pancreatic ductal adenocarcinoma.